Related Experiment Video
Updated: Jun 2, 2026

A Modified Murine Heterotopic Heart Transplant Protocol Matching Contemporary Standards of Aseptic Technique, Anesthesia, and Analgesia
Published on: September 28, 2022
Long-term mortality in adult orthotopic heart transplant recipients
Sung-Ho Jung1, Jae Joong Kim, Suk Jung Choo
1Department of Thoracic and Cardiovascular Surgery, Asan Medical Center, College of Medicine, University of Ulsan, Seoul, Korea.
Insights
Heart transplantation offers excellent surgical results for end-stage heart failure. Long-term survival is primarily impacted by infection, malignancy, and rejection, not cardiac allograft vasculopathy.
Area of Science:
- Cardiology
- Transplantation Medicine
- Immunology
Background:
- Heart transplantation is the primary treatment for end-stage heart failure.
- Improving long-term outcomes is crucial for patient survival.
Purpose of the Study:
- To analyze causes of death after heart transplantation.
- To identify factors influencing long-term survival post-transplant.
Main Methods:
- Retrospective analysis of 201 adult heart transplant recipients (1992-2008).
- Evaluation of mortality causes and survival rates at 1, 5, and 10 years.
- Utilized bicaval anastomosis technique since 1999.
Main Results:
- In-hospital mortality was 1% due to sepsis.
- Late mortality occurred in 19.4% of patients, predominantly from sepsis.
- 1-, 5-, and 10-year survival rates were 95.5%, 86.9%, and 73.5%, respectively.
- Cardiac deaths were rare.
Conclusions:
- Adult heart transplantation yields excellent surgical results.
- Long-term mortality is mainly attributed to infection, malignancy, and rejection.
- Infection remains a significant cause of late death post-heart transplant.
Abstract:
Heart transplantation is now regarded as the treatment of choice for end-stage heart failure. To improve long-term results of the heart transplantation, we analyzed causes of death relative to time after transplantation. A total of 201 consecutive patients, 154 (76.6%) males, aged ≥ 17 yr underwent heart transplantation between November 1992 and December 2008. Mean ages of recipients and donors were 42.8 ± 12.4 and 29.8 ± 9.6 yr, respectively. The bicaval anastomosis technique was used since 1999. Mean follow up duration was 6.5 ± 4.4 yr. Two patients (1%) died in-hospital due to sepsis caused by infection. Late death occurred in 39 patients (19.4%) with the most common cause being sepsis due to infection. The 1-, 5-, and 10-yr survival rates in these patients were 95.5% ± 1.5%, 86.9% ± 2.6%, and 73.5% ± 4.1%, respectively. The surgical results of heart transplantation in adults were excellent, with late mortality due primarily to infection, malignancy, and rejection. Cardiac deaths related to cardiac allograft vasculopathy were very rare.
Related Concept Videos
Kidney Transplant I: Introduction
Tissue Transplantation
The Biology of Tissue Transplantation
The biology of tissue transplantation hinges on the Major Histocompatibility Complex (MHC) molecules. These molecules...

